RT Journal Article
SR Electronic
T1 Association between Positive Airway Pressure Adherence and Healthcare Costs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.10.21263396
DO 10.1101/2021.09.10.21263396
A1 Jaejin An
A1 Henry A. Glick
A1 Amy M. Sawyer
A1 Jessica Arguelles
A1 Charles J. Bae
A1 Aiyu Chen
A1 Brendan T. Keenan
A1 Samuel T. Kuna
A1 Greg Maislin
A1 Diego R. Mazzotti
A1 Allan I. Pack
A1 Jiaxiao M. Shi
A1 Alexa J. Watach
A1 Dennis Hwang
YR 2021
UL http://medrxiv.org/content/early/2021/09/15/2021.09.10.21263396.abstract
AB Background The impact of positive airway pressure (PAP) therapy for obstructive sleep apnea (OSA) on healthcare costs is uncertain.Research Question Are three-year healthcare costs associated with PAP adherence in participants from the Tele-OSA clinical trial?Study Design and Methods Participants with OSA and prescribed PAP in the Tele-OSA study were stratified into three PAP adherence groups based on usage patterns over three years: (a) high (consistently ≥ 4 hours/night); (b) moderate (2-3.9 hours/night or inconsistently ≥ 4 hours/night); (c) low (<2 hours/night). Using data from three months of the Tele-OSA trial and 33 months of post-trial follow-up, average healthcare costs (2020 US dollars) in six-month intervals were derived from electronic health records and analyzed using multivariable generalized linear models.Results Of 543 participants, 25% were categorized as having high adherence, 22% moderate adherence, and 52% low adherence to PAP therapy. Average (standard deviation) PAP use was 6.5 (1.0) hours, 3.7 (1.2) hours, and 0.5 (0.5) hours for the high, moderate, and low adherence groups, respectively. The high adherence group had the lowest average [standard error] covariate-adjusted six-month healthcare costs ($3,162 [$240]) compared with the moderate ($3,658 [$369]) and low ($4,016 [$315]) adherence groups. Significant cost savings were observed between the high and low adherence groups ($854 [95% CI $158, $1,551]); savings between moderate and low adherence were non-significant ($359 [95% CI -$459, $1,176]).Interpretation In participants with OSA, better PAP adherence was associated with significantly lower healthcare costs over three years. Findings support the importance of strategies to enhance long-term PAP adherence.Competing Interest StatementAn, Glick, Bae: No conflicts to disclose Sawyer: Research funding from National Institutes of Health and Veterans Affairs HSR&D. Mazzotti: Research funding from AASM Foundation, American Heart Association and National Institutes of Health. Hwang: Research funding from AASM Foundation, National Institutes of Health, and Kaiser Permanente Southern California Research and Evaluation Clinical Investigator Program. Watach: Research training supported by National Institutes of Health. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Funding StatementNo funding was provided for this research. The Tele-OSA Study was originally supported by funding from the American Sleep Medicine Foundation Strategic Research Award 104-SR-13 and equipment support from ResMed Corp.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Tele-OSA study and all subsequent analyses based on the study cohort were approved by the Kaiser Permanente Southern California Institutional Review Board. Participant written informed consent was waived for the entire study, including the epidemiologic follow-up, due to the minimal risk of the study interventions and data collection procedures.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data that support the findings of this study may be made available from the investigative team with the following conditions: 1) agreement to collaborate with the study team on all publications, 2) provision of external funding for administrative and investigator time necessary for this collaboration, 3) demonstration that the external investigative team is qualified and has documented evidence of training for human subjects protections, and 4) agreement to abide by the terms outlined in data use agreements between institutions.AHIApnea Hypopnea IndexANOVAanalysis of varianceBMIbody mass indexCPTCurrent Procedural TerminologyDMEdurable medical equipmentGLMgeneralized linear modelsHCPCSHealthcare Common Procedure Coding SystemNADACNational Average Drug Acquisition CostOSAObstructive sleep apneaPAPpositive airway pressure